INO:NASDAQ
Inovio Pharmaceuticals Inc
1,40 USD
0,00%
(0,00) 1D
1,39 USD
arrow_downward
-0,71% (-0,0100)todayPre-market
Closed: 16-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Mkt. cap
262,23 млн
Avg. vol.
19,46 млн
Volume
181,87 миң
52-wk high
2,72 USD
52-wk low
0,56 USD
EPS
-0,80 USD
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
Mkt. cap
262,23 млн
Avg. vol.
19,46 млн
Volume
181,87 миң
52-wk high
2,72 USD
52-wk low
0,56 USD
EPS
-0,80 USD
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
News stories
From web sources and news partners
The Business Journals
·
45 мүнөт мурун
After 43 years, Inovio gets its first FDA-approved drug in 'milestone' decision
MarketWatch
·
15 саат мурун
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc